V015-1075 Screening compound: 2-(4-benzylpiperidin-1-yl)-N-[(oxolan-2-yl)methyl]-5-({[4-(trifluoromethyl)phenyl]carbamoyl}amino)benzamide

V015-1075 Screening compound: 2-(4-benzylpiperidin-1-yl)-N-[(oxolan-2-yl)methyl]-5-({[4-(trifluoromethyl)phenyl]carbamoyl}amino)benzamide
V015-1075 Screening compound: 2-(4-benzylpiperidin-1-yl)-N-[(oxolan-2-yl)methyl]-5-({[4-(trifluoromethyl)phenyl]carbamoyl}amino)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V015-1075
2-(4-benzylpiperidin-1-yl)-N-[(oxolan-2-yl)methyl]-5-({[4-(trifluoromethyl)phenyl]carbamoyl}amino)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V015-1075

Molecular Formula

C32H35F3N4O3 (C32 H35 F3 N4 O3)

Compound Name

2-(4-benzylpiperidin-1-yl)-N-[(oxolan-2-yl)methyl]-5-({[4-(trifluoromethyl)phenyl]carbamoyl}amino)benzamide

IUPAC name

2-(4-benzylpiperidin-1-yl)-N-[(oxolan-2-yl)methyl]-5-({[4-(trifluoromethyl)phenyl]carbamoyl}amino)benzamide

SMILES

O=C(c(cc(cc1)NC(Nc2ccc(C(F)(F)F)cc2)=O)c1N1CCC(Cc2ccccc2)CC1)NCC1OCCC1

InChI

InChI=1S/C32H35F3N4O3/c33-32(34,35)24-8-10-25(11-9-24)37-31(41)38-26-12-13-29(28(20-26)30(40)36-21-27-7-4-18-42-27)39-16-14-23(15-17-39)19-22-5-2-1-3-6-22/h1-3,5-6,8-13,20,23,27H,4,7,14-19,21H2,(H,36,40)(H2,37,38,41)/t27-/m1/s1

InChI Key

PTUGYTAWJWQJEO-HHHXNRCGSA-N

MDL Number (MFCD)

MFCD14241775

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

580.65

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

7.104

Distribution Coefficient, logD

7.104

Water Solubility, LogSw

-6.27

Polar Surface Area

68.489

Acid Dissociation Constant (pKa)

12.55

Base Dissociation Constant (pKb)

4.04

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

37.50

V015-1075 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds

References: we are preparing a list of scientific research reports with V015-1075 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V015-1075?
Check Price and Availability of V015-1075, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V015-1075 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V015-1075
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V015-1075
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V015-1075 available by request